Shenzhen Quanxinhao(000007)
Search documents
零售板块再度走高,全新好等多股涨停
Mei Ri Jing Ji Xin Wen· 2025-12-15 03:28
Group 1 - The retail sector has seen a significant rise, with stocks such as All New Good, Agricultural Products, and Zhejiang Dongri hitting the daily limit up [1] - Other companies like Hangzhou Xie Bai, Central Market, Great Eastern, Bubugao, and Yonghui Supermarket also experienced gains [1]
深圳证监局下发《行政监管措施决定书》,查明全新好存在四项问题
Zhong Guo Ji Jin Bao· 2025-12-12 05:41
【导读】深圳证监局下发《行政监管措施决定书》,查明全新好存在四项问题 全新好 3 [4] 000007 L1 ▼ 10.09 今开 10.28 最高 10.36 最低 10.05 -1.56% -0.16 换手☺ 2.63% 总手 91261 金额 9269万 更多 息值☺ 34.96亿 流值 34.96亿 市盈 "⊙ 767.05 ◀ 股东大会:于2025-12-15召开2025年第一次临 ... ○ × 分时 五日 日K 要名, DK点, 前复权 均线▼ MA5:10.07↓10:10.25↑20:9.97↑ 11.09-> 11.09 10.01 8.92 7.84 主力意愿 ▼ 解锁查看完整K线数据 2110.49 20250804 20251211 20250910 20251030 监管查明全新好存在四项问题 一是财务核算不规范。2022年至2024年,全新好的房屋租赁业务,在财务核算上未考虑免租期影响;外 销业务收入确认时点与披露政策不符且存在跨期情形;外销杀菌纸巾业务收入确认不规范。 全新好的上述情形不符合《企业会计准则第21号——租赁》第四十五条、《企业会计准则第14号——收 入》第四条、第 ...
000007,查明四项问题!
Zhong Guo Ji Jin Bao· 2025-12-12 05:33
Core Viewpoint - Shenzhen Securities Regulatory Bureau has identified four issues with the company "全新好" related to financial accounting, information disclosure, internal control, and corporate governance [2][6]. Group 1: Financial Accounting Issues - The company failed to consider the impact of rent-free periods in its financial accounting for its rental business from 2022 to 2024 [5]. - Revenue recognition for external sales did not align with disclosure policies and included cross-period situations [5]. - Revenue recognition for the external sales of disinfectant wipes was not compliant with accounting standards [5]. Group 2: Information Disclosure Issues - The company misclassified disinfectant wipes and other daily necessities, leading to incorrect revenue disclosures in the annual reports for 2023 and 2024 [5]. Group 3: Internal Control Issues - The company exhibited inadequate control over its subsidiary, Jiangmen Duheng Paper Technology Co., Ltd., which does not comply with internal control guidelines [5]. Group 4: Corporate Governance Issues - The company failed to sign contracts with some directors and did not timely revise its insider information management system [5]. - There was a lack of proper documentation for insider information personnel, and these individuals did not confirm their records [5]. Group 5: Regulatory Actions - The Shenzhen Securities Regulatory Bureau has mandated corrective measures for the company and issued warning letters to key personnel, including the current and former chairpersons and general managers [7]. - The company is required to submit a written rectification report within 30 days of receiving the regulatory decision [7]. - The company must enhance the professional level of its financial personnel and improve its governance and internal control systems [8].
000007,查明四项问题!
中国基金报· 2025-12-12 05:31
Core Viewpoint - Shenzhen Securities Regulatory Bureau issued an administrative regulatory decision recognizing four issues with the company, involving financial accounting, information disclosure, internal control, and corporate governance [2][6]. Group 1: Financial Accounting Issues - The company failed to consider the impact of rent-free periods in its financial accounting for its housing leasing business from 2022 to 2024 [7]. - Revenue recognition timing for external sales did not align with disclosure policies and included cross-period situations [7]. - Revenue recognition for the external sales of disinfectant wipes was not compliant with accounting standards [7]. Group 2: Information Disclosure Issues - The company incorrectly classified disinfectant wipes and other daily necessities, leading to errors in revenue disclosure for the years 2023 and 2024 [7]. Group 3: Internal Control Issues - The company exhibited inadequate control over its subsidiary, Jiangmen Duheng Paper Technology Co., Ltd., which does not comply with internal control guidelines [7]. Group 4: Corporate Governance Issues - The company failed to sign contracts with some directors and did not timely revise its insider information management system, leading to non-compliance with regulations [7]. Group 5: Regulatory Measures - The Shenzhen Securities Regulatory Bureau decided to impose corrective measures on the company and issued warning letters to key personnel, including the current and former chairpersons and general managers [9]. - The company is required to submit a written rectification report within 30 days and must enhance the training of its board and senior management on securities laws and regulations [9][10].
12月12日重要公告一览
Xi Niu Cai Jing· 2025-12-12 03:00
Group 1 - Lu Kang Pharmaceutical plans to increase capital by 109 million yuan to its wholly-owned subsidiary Bio-Pesticide Company and 27 million yuan to Ze Run Company, aiming to expand its pesticide and sales sectors [1] - Hui Green Ecology intends to sell two properties in Ningbo for 12.52 million yuan, expecting a net profit impact of approximately 6.23 million yuan from the transaction [2] - Tianyuan Co., Ltd. plans to invest 185 million yuan in an intelligent upgrade project for its titanium dioxide production facilities [3] Group 2 - Metro Design has received approval from the Shenzhen Stock Exchange for its share issuance to acquire 100% equity of Guangzhou Metro Engineering Consulting Co., Ltd. for 511 million yuan [4] - South Network Energy announced a mid-term profit distribution plan for 2025, proposing a cash dividend of 0.07 yuan per 10 shares [5] - Qibin Group plans to establish two wholly-owned subsidiaries in Shenzhen with a registered capital of 100 million yuan each [6] Group 3 - All New Good received an administrative regulatory decision from the Shenzhen Securities Regulatory Bureau due to issues in financial accounting and information disclosure [7] - Luokai Co., Ltd. announced that its shareholders plan to reduce their holdings by up to 3% of the company's shares [8][9] - Jincheng Pharmaceutical's actual controller received an administrative penalty from the CSRC for stock manipulation, leading to the resignation of the chairman [10] Group 4 - Yicheng New Energy intends to acquire a 7.69% stake in Kaifeng Times for 10 million yuan, enhancing its strategic development [11] - Yujing Co., Ltd. signed a sales contract worth approximately 28.6 million USD with an overseas photovoltaic company [12] - Nuocheng Jianhua's TRK inhibitor, Zoltracitinib, has been approved for market entry in China [13] Group 5 - Nandu Power announced that its controlling shareholder is planning a change in control, leading to a temporary suspension of its stock [14] - Xinxing Casting plans to acquire 100% equity of China Resources Steel for 1.244 billion yuan to focus on special steel development [15] - Xinlitai is planning to issue H-shares and list on the Hong Kong Stock Exchange [16] Group 6 - Blue Fan Medical's subsidiary received approval for a new medical device, the coronary artery scoring balloon dilation catheter [18] - China Iron & Steel plans to establish a joint venture with several companies to provide new energy transportation solutions with a registered capital of 500 million yuan [19] - Jifeng Technology intends to sign a cooperation framework agreement with Dongtai Lianfei for a total transaction amount not exceeding 100 million yuan [20] Group 7 - Zhongwei Electronics announced a change in its actual controller, with stock resuming trading [21] - Weihong Co., Ltd. plans to reduce its holdings by up to 1.15% of the company's shares [22] - Te Fa Information received a criminal judgment related to a fraud case involving the acquisition of Shenzhen Te Fa Dongzhi Technology Co., Ltd. [23] Group 8 - Sunshine Dairy's controlling shareholder's concerted action plans to reduce holdings by up to 3% of the company's shares [24] - Meikailong reported that Taobao Holdings and New Retail Fund collectively reduced their H-shares by 30.616 million shares [25] - Xinjubang plans to issue H-shares and apply for listing on the Hong Kong Stock Exchange [26] Group 9 - Beite Technology's application for issuing A-shares to specific objects has been approved by the Shanghai Stock Exchange [28] - Victory Energy's controlling shareholder is planning a change in control, with stock resuming trading [29] - Jiutian Pharmaceutical signed a patent and technology transfer agreement for a small molecule analgesic drug project, with a total transfer fee not exceeding 400 million yuan [29]
全新好因未依法履行其他职责等违规行为被证监会责令改正
Sou Hu Cai Jing· 2025-12-11 17:20
证券之星消息,12月11日全新好公开信息显示,深圳市全新好股份有限公司,董事长邹林、总经理唐 乾、副董事长黄国铭、副总经理王其帅、董事会秘书陈伟彬、陈桂、陆波因未依法履行其他职责,信息 披露违规被中国证券监督管理委员会深圳监管局责令改正。 详细违规行为如下: (一)财务核算不规范2022年至2024年,公司房屋租赁业务财务核算未考虑免租期影响,外销业务收入确认 时点与披露政策不符且存在跨期情形,外销杀菌纸巾业务收入确认不规范。上述情形不符合《企业会计 准则第21号--租赁》第四十五条、《企业会计准则第14号--收入》第四条、第十三条、第三十四条的规 定。(二)信息披露不规范因对杀菌纸巾和其他日常用品分类错误,公司2023年、2024年年报对杀菌纸巾和 其他日常用品的收入披露错误,不符合《上市公司信息披露管理办法》(证监会令第182号,下同)第三条第 一款的规定。(三)内部控制不规范公司对孙公司江门市都合纸业科技有限公司管控不到位,不符合《企业 内部控制应用指引第1号——组织架构》第十条的规定。(四)公司治理不规范公司未与部分董事签订合 同、未及时修订完善内幕信息知情人登记管理制度、未对个别重大事项制作内幕信息 ...
全新好:关于拟变更会计师事务所的公告
Zheng Quan Ri Bao Zhi Sheng· 2025-12-11 13:38
(编辑 任世碧) 证券日报网讯 12月11日晚间,全新好发布公告称,公司于2025年12月11日召开第十二届董事会第二十 四次(临时)会议,审议通过了《关于聘任2025年度财务审计机构及内部控制审计机构的议案》,公司 董事会同意聘任大华所为公司2025年度财务报告审计机构和内部控制审计机构,聘用期一年。 ...
全新好(000007) - 关于拟变更会计师事务所的公告
2025-12-11 12:16
证券代码:000007 证券简称:全新好 公告编号:2025-030 深圳市全新好股份有限公司 关于拟变更会计师事务所的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 特别提示: 1. 2024 年度,中兴财光华会计师事务所(特殊普通合伙)对公司财务报告 出具了标准无保留意见的审计报告。 2. 拟聘任的会计师事务所名称:大华会计师事务所(特殊普通合伙)(以 下简称"大华所")。 3. 原聘任的会计师事务所名称:中兴财光华会计师事务所(特殊普通合伙) (以下简称"中兴财光华")。 4. 变更会计师事务所的原因:综合考量公司业务发展与审计需求,公司拟 聘任大华会计师事务所担任公司 2025 年度财务、内控审计机构。 (2) 成立日期:2012 年 2 月 9 日成立(由大华会计师事务所有限公司转制 为特殊普通合伙企业) (3) 组织形式:特殊普通合伙 (4) 注册地址:北京市海淀区西四环中路 16 号院 7 号楼 1101 (5) 首席合伙人:杨晨辉 (6) 截至 2024 年 12 月 31 日合伙人数量:150 人 5. 本次变更会计师事务所符合财政部、 ...
全新好(000007) - 关于收到深圳证监局行政监管措施决定书的公告
2025-12-11 12:16
证券代码:000007 证券简称:全新好 公告编号:2025-033 深圳市全新好股份有限公司 关于收到深圳证监局行政监管措施决定书的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载,误导性陈述或重大遗漏。 深圳市全新好股份有限公司(以下简称"公司")于近日收到中国证券监督 管理委员会深圳监管局(以下简称"深圳证监局")下发的《中国证券监督管理委 员会深圳监管局行政监管措施决定书》〔2025〕246 号(以下简称"《行政监管 措施决定书》")。根据相关要求,现披露如下: 一、《行政监管措施决定书》的主要内容 深圳市全新好股份有限公司、黄国铭、邹林、陆波、唐乾、陈桂、王其帅、 陈伟彬: 经查,深圳市全新好股份有限公司存在以下问题: (一)财务核算不规范 2022 年至 2024 年,公司房屋租赁业务财务核算未考虑免租期影响,外销业 务收入确认时点与披露政策不符且存在跨期情形,外销杀菌纸巾业务收入确认不 规范。上述情形不符合《企业会计准则第 21 号--租赁》第四十五条、《企业会 计准则第 14 号--收入》第四条、第十三条、第三十四条的规定。 公司对孙公司江门市都合纸业科技有限公司 ...
全新好(000007) - 深圳市全新好股份有限公司关于召开2025年第二次临时股东会的通知
2025-12-11 12:15
证券代码:000007 证券简称:全新好 公告编号:2025-031 深圳市全新好股份有限公司 关于召开 2025 年第二次临时股东会的通知 公司于 2025 年 12 月 11 日召开第十二届董事会第二十四次(临时)会议,决议定于 2025 年 12 月 29 日召开 2025 年第二次临时股东会。 3、本次会议的召集、召开符合《中华人民共和国公司法》《深圳证券交易所股票上 市规则》《深圳证券交易所上市公司自律监管指引第 1 号——主板上市公司规范运作》等 法律、行政法规、部门规章、规范性文件及《公司章程》的有关规定。 4、会议时间: (1)现场会议时间:2025 年 12 月 29 日 14:30 (2)网络投票时间:通过深圳证券交易所系统进行网络投票的具体时间为 2025 年 12 月 29 日 9:15-9:25,9:30-11:30,13:00-15:00;通过深圳证券交易所互联网投票系统投 票的具体时间为 2025 年 12 月 29 日 9:15 至 15:00 的任意时间。 5、会议的召开方式:现场表决与网络投票相结合。 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、 ...